Answers are grounded in this paper and cite their sources.
Mass spectrometry identifies Cbl as an EGFR-interacting protein, suggesting a role in radioresistance.
Figure S1. Identification of Cbl as a protein interacting with EGFR by mass spectrometry
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: